|Reviewer||Employment||Research Grant||Other Research Support||Speakers’ Bureau/Honoraria||Expert Witness||Ownership Interest||Consultant/Advisory Board||Other|
|Paul Barash||Yale University Medical Center||None||None||None||None||None||None||None|
|Paula Graling||Inova Fairfax Hospital||Inova Seed grant (compliance with surgical safety checklist across perioperative services)†||None||None||None||None||AORN (unpaid)*||None|
|Loren Hiratzka||Bethesda North Hospital||None||None||None||None||None||None||None|
|Jeffrey Riley||Mayo Clinic, Rochester||None||None||None||None||None||None||None|
|Marc Ruel||University of Ottawa Heart Institute||None||None||None||None||None||None||None|
|Doug Wiegmann||University of Wisconsin–Madison||US Department of Defense†||None||Grand rounds talk*||None||None||American College of Surgeons (unpaid)*||None|
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (1) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.